Ariel Precision Medicine is a Pittsburgh-based company that offers a new approach to personalized care for patients with complex, chronic disorders. They believe that each patient is unique and their care should reflect that, taking into account their individual combination of genetic and environmental risk factors. By analyzing genetics, environmental factors, and patient-specific data, Ariel provides comprehensive and actionable risk assessments to inform early detection, risk-reducing strategies, and treatment for diseases such as pancreatitis and pancreatic cancer.
With their ADVANCE platform, Ariel integrates genetic reports, medical and family history, patient health profiles, and lifestyle and environmental factors to offer personalized care at the fingertips of both patients and providers. Their goal is to minimize the effects of diseases and maximize the health and quality of life for their patients. Ariel Precision Medicine is committed to staying at the forefront of scientific evidence and providing valuable insights through their guides, webinars, and therapeutic development pipeline.
Generated from the website